Skip to content
OpenCapital
Get started

Gyre Therapeutics, Inc. GYRE Accrued Interest On Long Term Certificates Of Deposit

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10—

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%—

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0×0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept gyre:AccruedInterestOnLongTermCertificatesOfDeposit.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s accrued interest on long term certificates of deposit.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s accrued interest on long term certificates of deposit?
Gyre Therapeutics, Inc. (GYRE) reported accrued interest on long term certificates of deposit of -$647K in Q1 2026.
How has Gyre Therapeutics, Inc.'s accrued interest on long term certificates of deposit changed year-over-year?
Gyre Therapeutics, Inc.'s accrued interest on long term certificates of deposit decreased by 34.0% year-over-year, from -$483K to -$647K.